News

One of the ways a cancer-causing gene works up enough power to turn a normal cell into a cancer cell is by copying itself over and over, like a Xerox machine. Scientists have long noticed that when cancer-causing genes do that, they also scoop up some extra DNA into their copies.

Stanford and UMass Amherst develop a new way to help machine-learning designers build AI with safeguards against specific, undesirable outcomes such as racial and gender bias

Researchers have developed a breakthrough in marine invertebrate (sponge) cell culture. For the first time, they have accomplished a substantial increase in both the rate and number of cell divisions.

MIT researchers have developed a bot equipped with artificial intelligence that can beat human players in tricky online multiplayer games where player roles and motives are kept secret.

Hiring decisions are rife with human bias, leading some organizations to hand off at least part of their employee searches to algorithms that screen applicants. But new research raises questions about those algorithms and the tech companies who develop them.

Professor Nikolaus Rajewsky is a visionary: He wants to understand exactly what happens in human cells during disease progression, with the goal of being able to recognize and treat the very first cellular changes.

Researchers used a machine-learning approach to discover new ways of controlling the spatial organization of induced pluripotent stem cells.

CRISPR Therapeutics and Vertex Pharmaceuticals have announced their interim safety and efficacy results from the CTX001 CRISPR/Cas9 gene-editing human clinical trials - and they're promising.

Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acute myeloid leukemia.

Researchers have created a database called "BacFITBase" which characterizes bacterial genes relevant to the infection process in live organisms. The new database aims to aid the discovery of novel therapeutic targets for the creation of antibiotics.